Netrin-1 Treatment
Netrin-1 Treatment - Related Videos
04:26
Streptozocin Treatment: A Zebrafish Model of Type 1 Diabetes Mellitus
0 Views •
2023
This video describes the technique of creating a zebrafish model for Type 1 diabetes mellitus with the help of the drug Streptozocin, to study the pathophysiology of diabetic complications and metabolic memory.
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
0 Views •
Cited by 2 •
2024
This study illustrates the methodological potential of combining Yttrium-90 Trans-Arterial Radioembolization (Y-90 TARE) with an anti-PD-1 monoclonal antibody as an effective neoadjuvant strategy leading to hepatectomy in hepatocellular carcinoma (HCC) patients with a high initial recurrence risk. It emphasizes the safety, feasibility, and step-by-step procedural guidance of this approach.
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
0 Views •
Cited by 3 •
2022
This protocol describes a novel method to deliver oral combinational antiretroviral drugs that successfully suppress HIV-1 RNA replication in humanized mice.
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
0 Views •
Cited by 26 •
2013
Psoriasis is a chronic, immune-mediated inflammatory skin disease. The Goeckerman regimen, formulated for the treatment of psoriasis, consists of exposure to ultraviolet B (UVB) light and application of crude coal tar (CCT). The following protocol is for the administration of Goeckerman therapy for the treatment of moderate-to-severe psoriasis.
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
0 Views •
Cited by 31 •
2015
Here we outline the procedure for MRI-guided repetitive transcranial magnetic stimulation to the dorsomedial prefrontal cortex as an experimental treatment for major depressive disorder.
FAQs
The receptor engaged can change the response to netrin-1. Binding to DCC or UNC5 participates in signaling that influences axon growth and guidance while also affecting cell survival. Because these receptors can produce receptor-specific effects, experiments must consider which receptor pathways are active when evaluating neuronal responses to treatment.
Dosage and delivery determine how effectively netrin-1 can influence nervous tissue and whether its effects remain appropriately controlled. The overview identifies both factors as central to therapeutic value, alongside receptor-specific responses. Researchers therefore need to relate the administered amount and delivery strategy to observed changes in axon behavior, survival, or repair.
Developing and mature neural tissue can show distinct responses because netrin-1 acts on processes that change across nervous-system development and repair. Its effects on axon guidance may be especially relevant during development, whereas treatment studies in mature tissue must evaluate how the same cue influences regeneration, survival, or recovery after injury.
Netrin-1 signaling may influence more than axon position or extension; the overview also identifies synaptic function as a responsive process. This means treatment studies can examine whether receptor activation is associated with changes in neuronal connectivity-related function, while distinguishing those effects from altered cell survival or axon guidance.
A study can assess several distinct outcomes, including axon growth and guidance, neuronal survival, synaptic function, neural regeneration, and recovery after injury. Measuring more than one endpoint helps determine whether treatment affects developmental signaling, cellular maintenance, or repair-related responses, rather than assuming that improved axon growth represents an overall neural benefit.
The approach is being investigated in contexts that include neural regeneration, recovery after nervous-system injury, and treatment strategies for neurodegenerative disease. These applications reflect different research goals: promoting repair, supporting functional recovery, or addressing disease-related neural decline. Results must still be interpreted in relation to dosage, delivery, receptor effects, and tissue maturity.